COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
<p class="MsoNormal" style="text-align: justify; line-height: 200%; margin: 0cm 0cm 0pt; mso-layout-grid-align: none;"><span style="line-height: 200%; font-family: ";Times New Roman";,";serif";; font-size: 12pt;" lang="EN-US...
Main Authors: | Alessia Marcon, Khaled M. Musallam, M. Domenica Cappellini, Ali Taher |
---|---|
Format: | Article |
Language: | English |
Published: |
Mattioli1885
2009-06-01
|
Series: | Mediterranean Journal of Hematology and Infectious Diseases |
Subjects: | |
Online Access: | http://www.mjhid.org/article/view/5250 |
Similar Items
-
Coagulation and thrombotic risk in thalassemia intermedia
by: A.T. Taher, et al.
Published: (2011-12-01) -
Plasma substance P and soluble P-selectin as biomarkers of β-thalassemia induced hypercoagulability
by: Samia A. Ebeid, et al.
Published: (2014-06-01) -
Thromboembolic events in ß-Thalassemia major patients
by: Sawsan S. Abbas
Published: (2007-01-01) -
Evaluation of platelet aggregation in splenectomized beta-thalassemia major and intermedia patients
by: Mahdi Zahedpanah, et al.
Published: (2018-01-01) -
The Management of COVID-19-Related Coagulopathy: A Focus on the Challenges of Metabolic and Vascular Diseases
by: Mónika Szilveszter, et al.
Published: (2023-08-01)